Nomura Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nomura Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250,000	Closed	-$28.9M	–	2064
2023 Q3	$28.9M	Sell	250,000 -140,966	-36%	-$15.1M	0.08%	163
2023 Q2	$40.2M	Buy	390,966 +377,736	+2,855%	+$39.9M	0.11%	139
2023 Q1	$1.44M	Buy	+13,230	New	+$1.46M	﹤0.01%	904
2022 Q4	–	Sell	-404,500	Closed	-$33.6M	–	2017
2022 Q3	$25.1M	Buy	+404,500	New	+$28.3M	0.1%	156
2022 Q1	–	Sell	-8,904	Closed	-$960K	–	2687
2021 Q4	$960K	Sell	8,904 -207,396	-96%	-$22.6M	﹤0.01%	1227
2021 Q3	$23.8M	Buy	+216,300	New	+$22.5M	0.06%	187
2021 Q2	–	Sell	-35,750	Closed	-$3.29M	–	2628
2021 Q1	$3.29M	Buy	35,750 +18,250	+104%	+$1.54M	0.01%	691
2020 Q4	$1.28M	Buy	+17,500	New	+$1.3M	﹤0.01%	956
2019 Q2	–	Sell	-11,321	Closed	-$298K	–	1447
2019 Q1	$298K	Buy	+11,321	New	+$268K	﹤0.01%	985
2018 Q2	–	Sell	-35,683	Closed	-$506	–	1673
2018 Q1	$506	Buy	35,683 +16,450	+86%	+$243K	﹤0.01%	1199
2017 Q4	$282K	Buy	+19,233	New	+$270K	﹤0.01%	1416
2016 Q3	–	Sell	-20,690	Closed	-$340K	–	1469
2016 Q2	$340K	Buy	20,690 +7,990	+63%	+$129K	﹤0.01%	924
2016 Q1	$212K	Buy	+12,700	New	+$222K	﹤0.01%	1217

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nomura Holdings's HZNP Position: Q4 2023 in Review

Nomura Holdings sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 250,000 shares — an estimated $28.9M sold.

Nomura Holdings first reported a position in HZNP in Q1 2016 and held it in 13 quarters. The position peaked at $40.2M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Nomura Holdings reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Nomura Holdings sold 250,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $28.9M.
Nomura Holdings first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016 and held it in 13 quarters.
Nomura Holdings's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $40.2M in Q2 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Nomura Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.